Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1973-2025

BD TEXIUM CLOSED MALE LUER WITH FEMALE CAP, REF: 10012241-0500 Recall

BD TEXIUM CLOSED MALE LUER WITH FEMALE CAP, REF: 10012241-0500

FDA recall Class II

Ongoing

FDA lists this Class II recall for BD TEXIUM CLOSED MALE LUER WITH FEMALE CAP, REF: 10012241-0500. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1973-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
May 12, 2025
FDA report date
Jun 18, 2025
Quantity in commerce
1,655,300
Distribution
See key details
FDA cause
Process control

What is being recalled?

BD TEXIUM CLOSED MALE LUER WITH FEMALE CAP, REF: 10012241-0500

Affected model & UDI checker

Search the exact identifiers published for Z-1973-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
10012241-0500BD TEXIUM CLOSED MALE LUER WITH FEMALE CAP, REF: 10012241-0500Check source noticeNot specified
FDA code information

REF/UDI-DI/Lot(Expiration): 10012241-0500/10885403221705/23045145(April 3, 2026), 23045146(April 3, 2026), 23055091(May 4, 2026), 23065090(June 3, 2026), 23075107(July 5, 2026), 23095124(September 8, 2026), 23105027(October 3, 2026), 23115047(November 2, 2026), 23125146(December 5, 2026), 24015245(January 11, 2027), 24025887(February 7, 2027), 24026421(February 27, 2027), 24036126(March 25, 2027), 24045690(April 24, 2027), 24066893(June 25, 2027), 24075111(July 26, 2027), 24095556(September 24, 2027), 24125014(December 2, 2027), 23035049(March 1, 2026)

View the original FDA recall notice

Why was this product recalled?

Sterile, single use closed system drug transfer devices, standalone or on infusion sets or bonded syringes, may leak at the interface between the closed male luer component and the needle-free connector, which may cause procedure delay, treatment interruptions, exposure to hazardous drugs, and/or underdosing of medication.

What actions did BD SWITZERLAND SARL take?

On 5/12/2025, removal notices were mailed or emailed to Medical Director, Risk Manager, Medical Device Safety Officer, Nurse Managers, and Distributors who were asked to do the following: 1. Immediately review your inventory for affected product. Destroy all unused affected products subject to the recall following your institution s process for destruction. 2. Share this recall notification with all users within your facility network of the product to ensure they are also aware of this recall. 3. Complete the Customer Response Form via email to bdrc53@bd.com 4. In addition, distributors were asked to identify all customers that purchased any affected product and to provide a copy of the customer letter to all customers and to advise them of the removal notification. Report any complaints experienced with the use of this product to the firm's North American Regional Complaint Center: Phone: 1-844-823-5433 Mon-Fri 8:00am and 5:00pm CT, Email: productcomplaints@bd.com

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology